Cetera Investment Advisers’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,948
Closed -$25K 3939
2024
Q2
$25K Sell
10,948
-630
-5% -$2.41K ﹤0.01% 3634
2024
Q1
$50K Buy
+11,578
New +$40.3K ﹤0.01% 3566

Cetera Investment Advisers's GTHX Position: Q3 2024 in Review

Cetera Investment Advisers sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 10,948 shares — an estimated $25K sold.

Cetera Investment Advisers first reported a position in GTHX in Q1 2024 and held it in 2 quarters. The position peaked at $50K in Q1 2024. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

  • Cetera Investment Advisers reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Cetera Investment Advisers sold 10,948 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $25K.
  • Cetera Investment Advisers first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
  • Cetera Investment Advisers's G1 Therapeutics, Inc. Common Stock position peaked at $50K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Cetera Investment Advisers's 13F filing for Q3 2024, filed 13 Nov 2024.